Epithalon Coupon: Check the Code, Then the Access Code

The Epithalon coupon at the supplier linked below is PEPTIDEDECK, and applied to a single 10 mg vial it takes the order from $50.00 to $25.00. That claim is checkable in fifteen seconds and it needs no article to explain it: enter the code, watch the total, pay or do not.

What makes this order unusual is that a second code travels with it. The batch report for the product prints a report number and an access code next to the address of a verification page hosted by the laboratory that issued it. One code changes what you pay. The other is an offer to check the document against somebody other than the seller. Most of this page is about the second one, because the first takes a sentence.

Where both codes attach:

What the Epithalon coupon does to the order summary

One presentation, one code, four published quantity tiers. The tiers discount the list price rather than the discounted one, so the table below is the whole of the commercial picture.

The gap between the bottom row and the one above it is the point. Buying ten vials to save 10 percent leaves you paying $45.00 for something the code prices at $25.00. Whether the two mechanisms combine is simply not addressed in the published terms, and an undocumented behaviour is not a saving you can plan around, so this page does not assert one. The order summary is the authority. Carriage is free above $250, which the ten-vial tier clears at $450.00 and the five-vial tier misses by $12.50. The full per-milligram working, including the figure the batch report forces, is in our breakdown of what an Epithalon milligram costs.

The second code on this order

The certificate for batch 15-05260628 was certified on 23 May 2026 by Kovera Labs under report number KVR-2026-A36FF4. At the foot of the page, beside that report number, sits an access code and the address of a verification page at the issuing laboratory. The design intent is not subtle. A PDF hosted on a seller’s own domain is a file the seller controls; a report number and an access code that resolve at the laboratory are an invitation to confirm the document with the party that produced it.

We have not run that check, so we are describing the offer rather than the result. What we can say is that the offer is worth more than the percentage on the front of the document, because the failure mode this market actually has is not a laboratory reporting the wrong number. It is a document that never came from a laboratory at all. A report number, a named laboratory, a batch identifier and an access route to the issuer are the four things a fabricated certificate finds hardest to supply, and they are all on this page. The principle underneath is the one ICH Q2(R2) formalises for regulated work: a result is only as good as the traceable procedure behind it.

There is a fifth check, and it happens after the parcel arrives rather than before. The certificate records the batch as 15-05260628, the form as lyophilised powder, and the physical vial as red-capped with a silver crimp. Every one of those is visible on the object in your hand. A document that describes a different batch, or a different closure, is not the document for your vial.

What the discount is actually applied to

Half price is only interesting if the other half was worth something. On this batch the certificate reports purity at 99.312 percent against a specification of greater than 98 percent, identity confirmed by liquid chromatography with mass spectrometry, an endotoxin safety screen passed against a limit of 0.5 EU/mL or below, a microbial sterility screen returning no growth, a four-element heavy metals screen returning negative on arsenic, cadmium, lead and mercury, and net content measured at 9.64 mg against a 10 mg label with a stated tolerance of 10 percent.

That last figure is the reason to trust the rest of the page slightly more than you otherwise would. It is inside tolerance, it is under the label, and it costs the seller money to print: at $25.00 the real figure is $2.59 per measured milligram rather than $2.50 per labelled one. Fill weights vary in both directions, and the same measurement on this site has run the other way, with a Selank lot assaying 12.29 mg in a vial labelled 10 mg, worked through in our reading of what a Selank milligram costs. The direction is not the point. Measuring it and publishing it is.

Two of the results are weaker than they look, and a page that only reported the flattering ones would be doing the same job as the coupon. The endotoxin screen is recorded as a pass rather than as a measured concentration, and the certificate does not name the method behind it, where the compendial reference procedure would be USP Chapter 85. The metals come back as negative rather than as values under stated limits. The same seller has issued documents with numeric endotoxin figures and named assays on other compounds, which we set out in our look at the same code applied to a different batch report, so the difference is a property of this document rather than of the laboratory.

When half price is not a sale

A code that halves an order looks like an event, and the vocabulary around it is borrowed from events: the badge says 50 percent reduction, the old figure is struck through, the new one is set larger. Across this market that arrangement is a standing condition rather than a promotion. Over the run of articles this site has published on this seller, the same code has carried the same depth of reduction on every compound examined. A discount that never ends is a price.

That is not an accusation and it does not make the number wrong. Twenty-five dollars is what a vial costs, and it remains the lower of the two figures on offer. What it changes is how much weight the reduction should carry in a decision. If half off were a window that closed on Friday, urgency would be rational. If it is the operating price, then the only comparison that matters is $25.00 against what another seller charges for a vial with a comparable document behind it, and the struck-through $50.00 contributes nothing to that comparison.

The practical consequence is a change of question. Not how much am I saving, which is answered by a figure the seller chose, but what does this price include, which is answered by a laboratory. On this listing the answer runs to six results and a measured fill weight, and there are sellers in the same bracket whose answer is two results and a percentage in a large font. That is the axis where $25.00 either is or is not a good number, and no coupon field can tell you which.

One more piece of arithmetic that the framing tends to hide. Free carriage begins at $250, and a single discounted vial at $25.00 is nowhere near that threshold, so carriage is not free on it. Whatever the code does to the line item, the figure worth comparing against another seller is the one at the bottom of the order summary rather than the one beside the product.

What neither code settles

A checkout code establishes that a merchant configured a promotion. A verification code establishes that a document came from the laboratory it names. Neither says anything about whether the compound does what it is sold on, and the gap there is wide.

Epithalon is a synthetic tetrapeptide, four residues, Ala-Glu-Asp-Gly, PubChem CID 219042, formula C14H22N4O9, molecular weight 390.35. FDA and PubChem spell it Epitalon and the buying market spells it Epithalon; it is one molecule. It is marketed on telomere and longevity claims sourced very largely to one research group in St Petersburg, and this page reports that those claims are made rather than adopting them. No registered controlled human trial establishes a longevity outcome. FDA holds that compounded drugs containing epitalon may pose a risk for immunogenicity for certain routes of administration due to the potential for aggregation and peptide-related impurities, and that it lacks sufficient information to know whether the drug would cause harm if administered to humans. The nomination that would have placed it on the compounding bulks list was withdrawn, and it appears in none of the three categories of the 503A list updated on 14 May 2026. There is no approval, and there is no dosing information on this page, because there is nothing to base it on.